Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Back to Shop BPC-157 is a peptide supplied for commercial sourcing, research applications, and formulation development
doi: 10.1007/s00204-020-02826-y 232 KaruppagounderSSAlinLChenYBrandDBourassaMWDietrichKet al
Follow instructions below
Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
US$ 27.06
US$ 20.26
US$ 28.86
US$ 21.15
US$ 26.92
US$ 21.92
US$ 27.44
US$ 24.99
